Farber HW - Search Results

1

Relation of novel echocardiographic measures to invasive hemodynamic assessment in scleroderma-associated pulmonary arterial hypertension.

Gopal DM, Doldt B, Finch K, Simms RW, Farber HW, Gokce N. Gopal DM, et al. Among authors: farber hw. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1386-94. doi: 10.1002/acr.22307. Arthritis Care Res (Hoboken). 2014. PMID: 24515598 Free PMC article.

2

Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma.

Farber HW, Graven KK, Kokolski G, Korn JH. Farber HW, et al. J Rheumatol. 1999 May;26(5):1195-6. J Rheumatol. 1999. PMID: 10332990

3

Prothrombotic mechanisms in primary pulmonary hypertension.

Farber HW, Loscalzo J. Farber HW, et al. J Lab Clin Med. 1999 Dec;134(6):561-6. doi: 10.1016/s0022-2143(99)90094-x. J Lab Clin Med. 1999. PMID: 10595782 Free article. Review.

4

Systemic sclerosis-associated pulmonary hypertension: short- and long-term effects of epoprostenol (prostacyclin).

Klings ES, Hill NS, Ieong MH, Simms RW, Korn JH, Farber HW. Klings ES, et al. Among authors: farber hw. Arthritis Rheum. 1999 Dec;42(12):2638-45. doi: 10.1002/1529-0131(199912)42:12<2638::AID-ANR20>3.0.CO;2-X. Arthritis Rheum. 1999. PMID: 10616012 Free article.

5

Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension.

Aguilar RV, Farber HW. Aguilar RV, et al. Among authors: farber hw. Am J Respir Crit Care Med. 2000 Nov;162(5):1846-50. doi: 10.1164/ajrccm.162.5.2004042. Am J Respir Crit Care Med. 2000. PMID: 11069824

6

HIV-associated pulmonary hypertension.

Farber HW. Farber HW. AIDS Clin Care. 2001 Jun;13(6):53-5, 59. AIDS Clin Care. 2001. PMID: 11710309 No abstract available.

7

The pathogenesis of HIV-associated pulmonary hypertension.

Klings ES, Farber HW. Klings ES, et al. Among authors: farber hw. Adv Cardiol. 2003;40:71-82. doi: 10.1159/000073176. Adv Cardiol. 2003. PMID: 14533547 Review. No abstract available.

8

Pulmonary arterial hypertension.

Farber HW, Loscalzo J. Farber HW, et al. N Engl J Med. 2004 Oct 14;351(16):1655-65. doi: 10.1056/NEJMra035488. N Engl J Med. 2004. PMID: 15483284 Review. No abstract available.

9

Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment.

Fisher KA, Serlin DM, Wilson KC, Walter RE, Berman JS, Farber HW. Fisher KA, et al. Among authors: farber hw. Chest. 2006 Nov;130(5):1481-8. doi: 10.1378/chest.130.5.1481. Chest. 2006. PMID: 17099027

10

Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression.

Klings ES, Anton Bland D, Rosenman D, Princeton S, Odhiambo A, Li G, Bernard SA, Steinberg MH, Farber HW. Klings ES, et al. Among authors: farber hw. Am J Hematol. 2008 Jul;83(7):547-53. doi: 10.1002/ajh.21187. Am J Hematol. 2008. PMID: 18383329 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters